Alexander Zehnder

Alexander Zehnder, MD, MBA, currently serves as the Chief Executive Officer of CureVac since April 2023. Prior to this role, Alexander Zehnder held multiple leadership positions at Sanofi Genzyme from October 2014 to February 2023, including Global Head Oncology, as well as President & Managing Director for Italy and Malta. Alexander Zehnder’s experience at Roche spanned from January 2004 to September 2014, notably as General Manager for Roche Greece and Cyprus, VP of Global Product Strategy and Global Franchise Head for Avastin, and Global Lifecycle Leader for Avastin. Academic qualifications include a Doctor of Medicine (M.D.) from the University of Bern and a Master of Business Administration (MBA) from IMD.